The Radboud University Medical Center and Faculty of Science announce the Radboud Consortium for Glycoscience (RCG). After the genome and proteome, the glycome offers a novel perspective to understand human disease biology. Glycoscience also plays a central role in biomass conversion, food and pharma industries. Via a 220.000 euro interfaculty grant, researchers from Radboud University will combine their multidisciplinary knowledge to develop educational programs and unclose research facilities and expertise in the field of Glycoscience.Carbohydrates are the most abundant biomolecules on earth and play a central role in biomass conversion, food and pharma industries. Glycans are composed of monosaccharides and occur ubiquitously in all organisms. Glycosylation is the process by which proteins are modified with different glycans. Although the biological language of our DNA and proteins is already well understood, this is certainly not the case for protein glycosylation. Glycoscience combines these novel fields of research and will significantly impact a broad range of research topics, ranging from evolutionary biology to food, biomass, and personalized medicine. To grasp the full potential of Glycoscience, novel technologies for their synthesis and analysis are needed.
Groups within Radboud University have strongly contributed to the international development of the field of Glycoscience with novel synthetic and biological concepts, advanced characterization methods, diagnosis and treatment of human diseases and novel functions for glycans in infectiology and oncology. A multidisciplinary approach is essential to significantly progress in this novel field. The Radboud Consortium for Glycoscience aims to advance these initiatives and to bring scientists together to stimulate new collaborations and developments in Glycoscience. The RCG will develop a teaching program on Glycoscience, will provide a platform for researchers to discuss their Glycoscience related research questions and will develop novel analytical and synthetic methodology for use in new research projects.
More information: link or send an email to: email@example.com
Related news items
Dutch Brain Foundation grant for EENnacoma20 February 2020
Lavrijsen and Van Erp: ‘This grant will facilitate practice-based research, professionalization and further academization of EENnacoma, and links between different health care and research institutions all for the benefit of people with prolonged disorders of consciousness and their families.'read more
RIHS Awards Ceremony five winners19 February 2020
On 18 February the RIHS 'Koek & Zopie' event took place. In front of an audience of more than 125 colleagues, RIHS awardees accepted their awards for the best PhD thesis, the research product with the highest impact on society, the best peer-reviewed publication and the Supervisor of the year 2019.read more
Preserved specific force in facioscapulohumeral muscular dystrophy19 February 2020
DCMN researcher Saskia Lassche et al., theme Disorders of Movement, recently showed in Neurology that remaining muscle fibers in Facioscapulohumeral muscular dystrophy (FSHD) patients have normal muscle strength, even in severely affected muscles.read more
Researchers investigate how stem cells affect the immune system18 February 2020
RIMLS researchers Irma Joosten and Renate van der Molen, participating in an European study into the treatment of brain damage in premature babies. Is it possible to limit or even partly repair the damage with stem cells? They focus primarily on the effect of those stem cells on the immune system.read more
Lowlands Science call for projects17 February 2020
Researchers pay attention! Lowlands is looking for research teams to participate in Lowlands Science 2020. It’s a great way to reach a large audience, do unique experiments with and on them, and to have a memorable experience with your colleagues.read more